insights_auto
Why is GMAB up 4.70%?
Dive Deeperchevron_right
GMAB:NASDAQ
Genmab A/S - ADR
$38.74
arrow_upward
+4.70%(+1.74) 1D
Oct 19, 1:27:11 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GMAB...
Open
$37.89
High
$39.00
Low
$37.76
Mkt. cap
24.54B
Avg. vol.
3.41M
Volume
3.07M
P/E ratio
30.53
52-wk high
$40.17
52-wk low
$23.62
EPS
$1.27
Beta
0.81
Shares outstanding
624.06M
No. of employees
3K
Open
$37.89
High
$39.00
Low
$37.76
Mkt. cap
24.54B
Avg. vol.
3.41M
Volume
3.07M
P/E ratio
30.53
52-wk high
$40.17
52-wk low
$23.62
EPS
$1.27
Beta
0.81
Shares outstanding
624.06M
No. of employees
3K
News stories
From web sources and news partners
marketscreener.com
·
10 minutes ago
Exchange-Traded Funds Higher as US Equities Rise After Midday
FXStreet
·
1 hour ago
The S&P 500 is on a dangerous path
ChartMill
·
1 hour ago
S&P 500 Top Movers: Gainers and Losers in Today's Session
TradingView
·
3 hours ago
The Dow Jones Index Opens 0.08% Lower
Profile
Genmab A/S is a Danish biotechnology company, founded in February 1999 by Florian Schönharting, at the time managing director of BankInvest Biomedical venture fund. The company is based in Copenhagen, Denmark – internationally, it operates through the subsidiaries Genmab B.V. in Utrecht, The Netherlands, Genmab U.S., Inc. in Princeton, New Jersey, US, Genmab K.K. in Tokyo, Japan, Genmab Germany GmbH in München, Germany and Genmab Co., Ltd. in Suzhou, China. Genmab is listed on the Copenhagen Stock Exchange in Denmark, with American depositary receipts traded on the NASDAQ in the US. Wikipedia
About Genmab A/S - ADR
CEOJan G. J. van de Winkel
Employees3.12K
Founded1999
Headquarters-
SectorBiotechnology
Websitegenmab.com